Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Hisse Senetlerindeki Sıralama #29900
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Hisse Fiyatı
$1.10
Son senkronizasyon: 2023-06-07
Piyasa Değeri
$19.12M
Değişim (1 gün)
-0.90%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

Satsuma Pharmaceuticals, Inc. (STSA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.08 - 2023-06-01

Gün sonu en düşük fiyat: $15.51 - 2019-09-01
Satsuma Pharmaceuticals, Inc. için hisse fiyatı geçmişi: 2019 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$743.14 7.12%
CH
$1.07K -5.58%
KR